Literature DB >> 33624173

Guide to Enhanced Recovery for Cancer Patients Undergoing Surgery: Pancreaticoduodenectomy.

Ahmad Hamad1, Timothy M Pawlik1, Aslam Ejaz2.   

Abstract

INTRODUCTION: Pancreaticoduodenectomy (PD) is a highly complex operation with high rates of morbidity and significant potential for perioperative mortality. Enhanced recovery after surgery protocols following PD aim to standardize post-operative clinical pathways in an effort to decrease surgical stress, minimize practice variation, and accelerate postoperative recovery. We reviewed current evidence and provide recommendations for enhanced recovery after PD protocols.
METHODS: Current evidence regarding enhanced recovery after PD were reviewed. Recommendations for enhanced recovery after PD protocols are provided based on evidence and expert opinion.
RESULTS: Key clinical factors required for a enhanced recovery after PD protocol to reduce postoperative complications and promote a faster recovery include patient and provider education, preoperative oral nutrition until 2-3 h prior to surgery, goal-directed intravenous fluid management, early advancement of oral diet, multimodal analgesia, early mobilization, normoglycemia, and early removal of intra-abdominal drains when clinically indicated. A PD specific protocol has been shown to reduce rates of PD-specific and overall complications as well as shorten postoperative hospital length of stay.
CONCLUSION: The key facilitator to a successful enhanced recovery after PD protocol is careful multi-disciplinary planning with input from all stakeholders. Evidenced-based enhanced recovery protocols have been shown to reduce postoperative morbidity and accelerate postoperative recovery following PD.
© 2021. Society of Surgical Oncology.

Entities:  

Mesh:

Year:  2021        PMID: 33624173     DOI: 10.1245/s10434-021-09717-1

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  10 in total

1.  Reply to: epidural analgesia utilization rate for hepatic and pancreatic surgery, that low?

Authors:  Neda Amini; Yuhree Kim; Timothy M Pawlik
Journal:  Am J Surg       Date:  2015-12-15       Impact factor: 2.565

Review 2.  Implementation of ERAS and how to overcome the barriers.

Authors:  Arman Kahokehr; Tarik Sammour; Kamran Zargar-Shoshtari; Lisa Thompson; Andrew G Hill
Journal:  Int J Surg       Date:  2008-12-03       Impact factor: 6.071

3.  Smad3 binds Scleraxis and Mohawk and regulates tendon matrix organization.

Authors:  Ellora Berthet; Carol Chen; Kristin Butcher; Richard A Schneider; Tamara Alliston; Mohana Amirtharajah
Journal:  J Orthop Res       Date:  2013-05-07       Impact factor: 3.494

4.  Guidelines for perioperative care for pancreaticoduodenectomy: Enhanced Recovery After Surgery (ERAS®) Society recommendations.

Authors:  Kristoffer Lassen; Marielle M E Coolsen; Karem Slim; Francesco Carli; José E de Aguilar-Nascimento; Markus Schäfer; Rowan W Parks; Kenneth C H Fearon; Dileep N Lobo; Nicolas Demartines; Marco Braga; Olle Ljungqvist; Cornelis H C Dejong
Journal:  Clin Nutr       Date:  2012-09-26       Impact factor: 7.324

5.  Measuring surgical quality: a national clinical registry versus administrative claims data.

Authors:  Laura M Enomoto; Christopher S Hollenbeak; Neil H Bhayani; Peter W Dillon; Niraj J Gusani
Journal:  J Gastrointest Surg       Date:  2014-06-14       Impact factor: 3.452

6.  Assessment of complications after pancreatic surgery: A novel grading system applied to 633 patients undergoing pancreaticoduodenectomy.

Authors:  Michelle L DeOliveira; Jordan M Winter; Markus Schafer; Steven C Cunningham; John L Cameron; Charles J Yeo; Pierre-Alain Clavien
Journal:  Ann Surg       Date:  2006-12       Impact factor: 12.969

7.  A novel, validated risk score to predict surgical site infection after pancreaticoduodenectomy.

Authors:  Katherine E Poruk; Joseph A Lin; Michol A Cooper; Jin He; Martin A Makary; Kenzo Hirose; John L Cameron; Timothy M Pawlik; Christopher L Wolfgang; Frederic Eckhauser; Matthew J Weiss
Journal:  HPB (Oxford)       Date:  2016-09-10       Impact factor: 3.647

8.  Hospital variation in Textbook Outcomes following curative-intent resection of hepatocellular carcinoma: an international multi-institutional analysis.

Authors:  Diamantis I Tsilimigras; Rittal Mehta; Katiuscha Merath; Fabio Bagante; Anghela Z Paredes; Ayesha Farooq; Francesca Ratti; Hugo P Marques; Silvia Silva; Olivier Soubrane; Vincent Lam; George A Poultsides; Irinel Popescu; Razvan Grigorie; Sorin Alexandrescu; Guillaume Martel; Aklile Workneh; Alfredo Guglielmi; Tom Hugh; Luca Aldrighetti; Itaru Endo; Timothy M Pawlik
Journal:  HPB (Oxford)       Date:  2019-12-27       Impact factor: 3.647

9.  Enhancing Patient Outcomes while Containing Costs after Complex Abdominal Operation: A Randomized Controlled Trial of the Whipple Accelerated Recovery Pathway.

Authors:  Harish Lavu; Neal S McCall; Jordan M Winter; Richard A Burkhart; Michael Pucci; Benjamin E Leiby; Theresa P Yeo; Shawnna Cannaday; Charles J Yeo
Journal:  J Am Coll Surg       Date:  2019-01-17       Impact factor: 6.113

10.  Development of a novel rat model of heterogeneous hepatic injury by injection with colchicine via the splenic vein.

Authors:  Yan-Yan Zhang; Chao-Xu Zhang; Yu Li; Xuan Jiang; Yong-Fang Wang; Yang Sun; Jun Wang; Wan-Ying Ji; Yi Liu
Journal:  World J Gastroenterol       Date:  2018-11-28       Impact factor: 5.742

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.